These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
575 related articles for article (PubMed ID: 30388053)
1. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes. Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study. Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940 [TBL] [Abstract][Full Text] [Related]
3. microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study. Kunc M; Popęda M; Niemira M; Szałkowska A; Bieńkowski M; Pęksa R; Łacko A; Radecka BS; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Iżycka-Świeszewska E; Krętowski A; Żaczek AJ; Biernat W; Senkus-Konefka E Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32825530 [TBL] [Abstract][Full Text] [Related]
4. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
5. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations. Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896 [TBL] [Abstract][Full Text] [Related]
6. The transcardiac gradient of cardio-microRNAs in the failing heart. Marques FZ; Vizi D; Khammy O; Mariani JA; Kaye DM Eur J Heart Fail; 2016 Aug; 18(8):1000-8. PubMed ID: 27072074 [TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724 [TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related]
9. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168 [TBL] [Abstract][Full Text] [Related]
10. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608 [TBL] [Abstract][Full Text] [Related]
12. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. Wang K; Chen M; Wu W World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412 [TBL] [Abstract][Full Text] [Related]
13. Activin A regulates microRNAs and gene expression in LNCaP cells. Ottley EC; Nicholson HD; Gold EJ Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851 [TBL] [Abstract][Full Text] [Related]
14. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
15. Identification of microRNA signature and potential pathway targets in prostate cancer. Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression profile in retina and choroid in oxygen-induced retinopathy model. Desjarlais M; Rivera JC; Lahaie I; Cagnone G; Wirt M; Omri S; Chemtob S PLoS One; 2019; 14(6):e0218282. PubMed ID: 31188886 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer. McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016 [TBL] [Abstract][Full Text] [Related]
18. Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment. Toyama K; Kiyosawa N; Watanabe K; Ishizuka H Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926935 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis. Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA meta-signature of oral cancer: evidence from a meta-analysis. Zeljic K; Jovanovic I; Jovanovic J; Magic Z; Stankovic A; Supic G Ups J Med Sci; 2018 Mar; 123(1):43-49. PubMed ID: 29482431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]